Ohana Medical Billing, a full service medical billing and reimbursement companyProviding consistent high customer satisfaction and overall exceptional service to health care providers.
- Electronic Claim Submission
- A/R Management
- Electronic Funds Transfer
- Patient Billing
- Payment Posting
More About Our Company
Ohana Medical Billing LLC is a full service medical billing and reimbursement company who provides consistent high customer satisfaction, competitive rates and exceptional service to health care providers. We offer this service with a focus on the success of our clients and helping them receive the highest reimbursements possible.
Our billing service allows a practice to minimize the amount they spend dealing with paperwork, insurance companies and accounts receivable. That is why we are committed to reducing expenses, improving collections and pursuing insurance companies for money that is due.
For your convenience, we provide, electronic and paper claim submission, filing of primary and secondary claims, follow up on rejected and denied claims, along with follow up for accounts receivable. We also offer 24 hour account access with real time online reporting and monitoring.
If you succeed we succeed and we thrive on helping our clients to achieve that success.
- Recent Headlines
- --(Science Daily) Four simple tests could help GPs spot pneumonia and reduce unnecessary antibiotics.
--Testing for fever, high pulse rate, crackly breath sounds, and low oxygen levels could be key to helping GPs distinguish pneumonia from less serious infections, according to a large study published in the European Respiratory Journal.”
--Pneumonia is a severe lung infection that can be life-threatening and often requires treatment with antibiotics. However, it is notoriously difficult to discriminate from more common viral infections, against which antibiotics are ineffective. The researchers say that using these four measures could help patients get the treatment they need as well as reducing unnecessary antibiotic use, which is fueling a rise in drug-resistant infections. The study was led by Michael Moore, Professor of Primary Care Research at the University of Southampton, and funded by the National Institute for Health Research. He explained: "GPs see a huge number of patients with symptoms of a lower respiratory tract infection such as coughing, phlegm, wheezing and being short of breath. The vast majority of these will have a viral infection, which can range from being mild through to feeling extremely unwell. But antibiotics do not work well for these patients and have side effects, so they should be avoided..
--(Modern Healthcare) Unintended consequences: CMS'readmissions program might be harming patients.
--At St. Elizabeth Medical Center in Utica, N.Y., the CMS' Hospital Reduction Readmissions Program was an expensive wake-up call to hospital leaders that they needed to do a better job of preventing patients from making a U-turn after being discharged. The hospital was hit with a $397,153 penalty in 2013, the first year the CMS issued penalties under the program, according to a data analysis by Leavitt Partners. The medical center's revenue was $197 million that year. "Without a doubt, the penalty program wakes you up and makes you look at" readmissions, said Dr. Eric Yoss, senior vice president of quality at Mohawk Valley Health System, which operates St. Elizabeth. "If you previously wanted to ignore it, you don't anymore."
--(Forbes) Many People Don't Seem To Know That Taking Prescription Drugs Could Impair Their Driving. More than 45 million Americans will travel by car over the Thanksgiving holiday, AAA predicts, and a new study suggests that about one out of five of those behind the wheel will have taken a prescription drug that could impair their driving. On top of that, many of them aren't aware of the risk. The study authors used data from the most recent National Roadside Survey (NRS), conducted in 2013-2014 by the National Highway Traffic Safety Administration, to determine what proportion of drivers had been warned that the medication their doctor prescribed could impair their performance. Data were collected from randomly selected drivers at 60 different U.S. locations. Drivers 16 and older were eligible to participate in the voluntary, anonymous survey about alcohol and drug use. Those who agreed to be surveyed were also asked to provide a breath sample to measure alcohol content and a saliva sample for drug testing. The 2013-2014 NRS was the second to ask drivers about drug use but the first to ask whether the drug had been prescribed for them and, if so, whether they’d been warned that it could impair their driving. Those who reported taking a prescribed, potentially impairing medication within the previous two days were then asked if they had been warned that it could affect their driving. These are the categories of potentially impairing prescription drugs covered by the survey and some examples of them: Antidepressants (Prozac, Zoloft, Wellbutrin). Methadone and buprenorphine (Subutex, Suboxone), opioids that are used in medication-assisted treatment of substance use disorders. Morphine or codeine, which are prescription opioids for pain. Other prescription opioids (OxyContin and Vicodin), also used to treat pain. Barbiturates (phenobarbital). Benzodiazepines, which are tranquilizers (Xanax and Valium). Muscle relaxants (Soma and Flexeril). Sleep aids (Ambien and Lunesta). ADHD medications (Ritalin, Aderall and Concerta). Other amphetamines (Benzadrine and Dexedrine). Prescription diet pills (Tenuate and phentermine). Except for the last three types of drugs, the medications on this list could impair drivers by sedating them. Experimental studies have shown that certain tranquilizers have a substantially higher risk of impairment than alcohol and that opioids have a risk comparable to that of alcohol, the researchers write. On the other hand, ADHD medications and other amphetamines as well as prescription diet pills are stimulants, which can influence attention, aggressiveness and risk-taking, the study authors write. You likely won't fall asleep behind the wheel if you take a stimulant, but you could end up taking unnecessary risks while driving. A total of 7,405 drivers answered the prescription drug questions on the NRS, and 19.7% of them reported taking a potentially impairing prescription drug within the previous two days. Of those who had, four out of five of them, or 78.2%, to be exact, said the drug had been prescribed for them, so there had been an opportunity for a physician or a pharmacist to talk about the risk of impaired driving.